Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Nature Chemistry
|
November 23, 2023
Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning
David F Nippa, Kenneth Atz, Remo Hohler, et al.
Nature Communications
|
January 17, 2025
Author Correction: Prospective de novo drug design with deep interactome learning
Kenneth Atz, Leandro Cotos, Clemens Isert, et al.
Nature Communications
|
April 22, 2024
Prospective de novo drug design with deep interactome learning
Kenneth Atz, Leandro Cotos, Clemens Isert, et al.
Journal of Medicinal Chemistry
|
November 22, 2019
Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Achi Haider, Julian Kretz, Luca Gobbi, et al.
Chembiochem : a European Journal of Chemical Biology
|
November 28, 2024
Development of a Highly Selective NanoBRET Probe to Assess MAGL Inhibition in Live Cells
Thais Gazzi, Benjamin Brennecke, Valentas Olikauskas, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Achi Haider, Luca Gobbi, Julian Kretz, et al.
Theranostics
|
December 8, 2025
Translational molecular imaging and drug development in multiple sclerosis
Daniel Tay, Hazem Ahmed, Alyaa Dawoud, et al.
Nature Communications
|
November 25, 2025
Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimization
David F Nippa, Kenneth Atz, Yannick Stenzhorn, et al.
Chemical Science
|
March 20, 2026
Single-position ligand modifications tune CB<sub>2</sub>R activity by targeting the toggle switch
Rudolf L Z Ganzoni, Miroslav Kosar, Yongqi Han, et al.
Chimia
|
September 2, 2024
Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche's Endocannabinoid System Projects
Johannes Aebi, Kenneth Atz, Simon M Ametamey, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Nature Chemistry
|
November 23, 2023
Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning
David F Nippa, Kenneth Atz, Remo Hohler, et al.
Nature Communications
|
January 17, 2025
Author Correction: Prospective de novo drug design with deep interactome learning
Kenneth Atz, Leandro Cotos, Clemens Isert, et al.
Nature Communications
|
April 22, 2024
Prospective de novo drug design with deep interactome learning
Kenneth Atz, Leandro Cotos, Clemens Isert, et al.
Journal of Medicinal Chemistry
|
November 22, 2019
Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Achi Haider, Julian Kretz, Luca Gobbi, et al.
Chembiochem : a European Journal of Chemical Biology
|
November 28, 2024
Development of a Highly Selective NanoBRET Probe to Assess MAGL Inhibition in Live Cells
Thais Gazzi, Benjamin Brennecke, Valentas Olikauskas, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Achi Haider, Luca Gobbi, Julian Kretz, et al.
Theranostics
|
December 8, 2025
Translational molecular imaging and drug development in multiple sclerosis
Daniel Tay, Hazem Ahmed, Alyaa Dawoud, et al.
Nature Communications
|
November 25, 2025
Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimization
David F Nippa, Kenneth Atz, Yannick Stenzhorn, et al.
Chemical Science
|
March 20, 2026
Single-position ligand modifications tune CB<sub>2</sub>R activity by targeting the toggle switch
Rudolf L Z Ganzoni, Miroslav Kosar, Yongqi Han, et al.
Chimia
|
September 2, 2024
Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche's Endocannabinoid System Projects
Johannes Aebi, Kenneth Atz, Simon M Ametamey, et al.
Page
of 4